- Home
- AGCC vs ALEC Comparison
AGCC vs ALEC Comparison
Compare AGCC & ALEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AGCC | ALEC |
|---|---|---|
| Founded | 2020 | 2013 |
| Country | Taiwan | United States |
| Employees | N/A | N/A |
| Industry | Beverages (Production/Distribution) | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 209.9M | 241.2M |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | AGCC | ALEC |
|---|---|---|
| Price | $19.36 | $2.10 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $3.33 |
| AVG Volume (30 Days) | 63.0K | ★ 838.1K |
| Earning Date | 01-01-0001 | 05-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $21,045,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $45.24 |
| P/E Ratio | $168.97 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.23 | $0.87 |
| 52 Week High | $17.73 | $3.40 |
Technical Indicators
Market Signals| Indicator | AGCC | ALEC |
|---|---|---|
| Relative Strength Index (RSI) | 78.64 | 52.97 |
| Support Level | $8.61 | $1.22 |
| Resistance Level | N/A | $2.53 |
| Average True Range (ATR) | 2.09 | 0.19 |
| MACD | 0.75 | -0.03 |
| Stochastic Oscillator | 90.27 | 33.09 |
Price Performance
Historical ComparisonAbout AGCC Agencia Comercial Spirits Ltd Class A Ordinary Shares
Agencia Comercial Spirits Ltd specializes in the procurement, distribution, and sale of high-quality whiskies, including both bottled and cask whisky in both Taiwan and international markets. The company's product portfolio includes the distribution of bottled whisky, raw cask whisky, and proprietary brand whisky.
About ALEC Alector Inc.
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.